Tibet Rhodiola Pharmaceutical Holding Co. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 1,373.105 million compared to CNY 1,256.021 million a year ago. Operating income was CNY 472.117 million compared to CNY 351.224 million a year ago. Net income was CNY 418.095 million compared to CNY 312.321 million a year ago. Basic earnings per share from continuing operations was CNY 1.69 compared to CNY 1.75 a year ago.